We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MEDICA Health IT Forum 2023 to Highlight General Digitalization Trends

By LabMedica International staff writers
Posted on 13 Oct 2023

This year, the MEDICA HEALTH IT FORUM will once again be a part of the renowned international medical trade fair MEDICA (Düsseldorf, Germany) scheduled for 13-16 November 2023. More...

The MEDICA HEALTH IT FORUM is a platform for innovations where attendees can experience top-class talks and sessions on the way to data-driven healthcare. In addition, there will be topic-related exhibits from leading universities and research institutions in the adjoining exhibition area, providing a comprehensive and tangible picture of digitally-optimized medicine.

The MEDICA HEALTH IT FORUM 2023 will bundle expertise and the latest developments and the pioneers of the industry will themselves be present. The forum 2023 will include expert panels with a keynote, followed by a series of statements and a panel discussion, as well as Q&A, a series of complementary tech talks, and open mic for exhibitor lectures & demonstrations. The complete program of the MEDICA HEALTH IT FORUM is as follows:

Monday, 13 November 2023

  • Drug discovery with AI
  • Quantum computing
  • Circularity in healthcare
  • Gamification
  • Female doctorpreneurship
  • Open mic

Tuesday, 14 November 2023

  • Predictive analytics
  • Healthcare metaverse
  • Chat GPT & Co.
  • Smart textiles
  • TikTok, Insta & Co. - Engaging, learning and networking on social media platforms
  • Green Hospital
  • Open mic

Wednesday, 15 November 2023

  • Data spaces & platforms
  • Consumer health
  • Safe AI
  • Circadian health
  • Digital empowerment
  • Open mic

Thursday, 16 November 2023

  • Digital mental health
  • Automation in healthcare / RPA
  • Health tech for the elderly
  • Medical education & digitization
  • Nutrition
  • Open mic

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i6000
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.